Brief: Synthaverse Receives Saudi Arabia Import Permit For BCG10 Vaccine
23/07/2026 08:23
BRIEF-Synthaverse Receives Saudi Arabia Import Permit For BCG10 Vaccine July 23 (Reuters) - Synthaverse SA SVEP.WA:
RECEIVES SAUDI ARABIA IMPORT PERMIT FOR BCG 10 VACCINE FOR DELIVERIES WORTH ABOUT EUR 344,000
FIRST DELIVERIES TO SAUDI ARABIA PUBLIC SECTOR PLANNED IN Q3 2026 AND REMAINING PART IN Q4 2026
Source text: https://tinyurl.com/5n8rrxwc
Further company coverage: SVEP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility